1. |
Woods AC,Duke JR.Coats diseaseⅠ:review of the literature,diagnostic criteria,clinical findings,and plasma lipid studies[J]. Br J Ophthalmol,1963,47:385-412.
|
2. |
Gomez MA.Coats' disease:natural history and results of treatment[J].Am J Ophthalmol,1965,60:855-865.
|
3. |
Shields JA, Shields CL, Honavar SG,et al.Classification and management of Coats disease:the 2000 Proctor Lecture[J].Am J Ophthalmol,2001,131:572-583.
|
4. |
Shapiro MJ,Chow CC, Karth PA, et al. Effects of green diode laser in the treatment of pediatric Coats disease[J]. Am J Ophthalmol,2011,151:725-731.
|
5. |
Mulvihill A, Morris B.A population-based study of Coats disease in the United Kingdom Ⅱ:investigation, treatment, and outcomes[J]. Eye (Lond),2010,24:1802-1807.
|
6. |
Mrejen S, Metge F, Denion E, et al. Management of retinal detachment in Coats disease:study of 15 cases[J]. Retina,2008,28(Suppl 3):S26-32.
|
7. |
Schefler AC, Berrocal AM,Murray TG.Advanced Coats' disease:management with repetitive aggressive laser ablation therapy[J]. Retina,2008,28(Suppl 3):S38-41.
|
8. |
Shields JA,Shields CL,Honavar SG,et al.Clinical variations and complications of Coats disease in 150 cases:the 2000 Sanford Gifford Memorial Lecture[J].Am J Ophthalmol,2001,131:561-571.
|
9. |
Adam RS,Kertes PJ,Lam WC.Observations on the management of Coats' disease:less is more[J]. Br J Ophthalmol,2007,91:303-306.
|
10. |
Othman IS,Moussa M,Bouhaimed M.Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone:effects and complications[J].Br J Ophthalmol,2010,94:606-610.
|
11. |
Bohm MR, Uhlig CE.Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema[J].Graefe's Arch Clin Exp Ophthalmol,2011,249:1099-1101.
|